| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.14e-07 | 38 | 123 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.29e-05 | 230 | 123 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.07e-05 | 118 | 123 | 6 | GO:0003774 | |
| GeneOntologyCellularComponent | myosin filament | 6.54e-09 | 25 | 125 | 6 | GO:0032982 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.92e-08 | 16 | 125 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin II complex | 6.21e-07 | 28 | 125 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | myofibril | 7.67e-07 | 273 | 125 | 11 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.39e-06 | 290 | 125 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | myosin complex | 1.41e-06 | 59 | 125 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcomere | 1.92e-05 | 249 | 125 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 5.71e-05 | 13 | 125 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | basement membrane | 9.30e-05 | 122 | 125 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 1.06e-04 | 3 | 125 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.34e-04 | 17 | 125 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | A band | 2.64e-04 | 52 | 125 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | perineuronal net | 1.55e-03 | 10 | 125 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.88e-03 | 11 | 125 | 2 | GO:0098966 | |
| HumanPheno | Waddling gait | 3.86e-07 | 130 | 39 | 9 | HP:0002515 | |
| HumanPheno | Weak cry | 3.01e-05 | 49 | 39 | 5 | HP:0001612 | |
| HumanPheno | Abnormality of the knee | HGD MYH3 FLNC MIA3 MAGEL2 GALNS FN1 CAMK2A LMBRD2 BCOR GBA2 RYR1 ASAH1 | 4.09e-05 | 491 | 39 | 13 | HP:0002815 |
| HumanPheno | Abnormal shoulder morphology | 7.31e-05 | 246 | 39 | 9 | HP:0003043 | |
| HumanPheno | Abnormality of jaw muscles | 7.96e-05 | 31 | 39 | 4 | HP:0045037 | |
| HumanPheno | Abnormal cry | 8.78e-05 | 61 | 39 | 5 | HP:0025429 | |
| HumanPheno | Abnormality of upper limb joint | HGD MYH2 MYH3 FLNC GALNS FKRP LAMA2 LMBRD2 IDS BCOR RYR1 CHRNE ASAH1 TMEM70 HEPHL1 | 1.12e-04 | 705 | 39 | 15 | HP:0009810 |
| HumanPheno | Abnormality of the joints of the lower limbs | HGD MYH3 FLNC MIA3 MAGEL2 GALNS FN1 CAMK2A LMBRD2 BCOR GBA2 RYR1 ASAH1 | 1.27e-04 | 547 | 39 | 13 | HP:0100239 |
| HumanPheno | Proximal muscle weakness in upper limbs | 1.48e-04 | 68 | 39 | 5 | HP:0008997 | |
| HumanPheno | Exercise-induced myalgia | 1.62e-04 | 37 | 39 | 4 | HP:0003738 | |
| MousePheno | decreased skeletal muscle fiber number | 2.99e-07 | 21 | 99 | 5 | MP:0009406 | |
| MousePheno | abnormal skeletal muscle fiber size | 6.32e-07 | 140 | 99 | 9 | MP:0009398 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 1.50e-06 | 80 | 99 | 7 | MP:0009404 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 2.50e-06 | 212 | 99 | 10 | MP:0003084 | |
| MousePheno | decreased skeletal muscle mass | 4.02e-06 | 131 | 99 | 8 | MP:0004819 | |
| MousePheno | abnormal skeletal muscle mass | 1.04e-05 | 149 | 99 | 8 | MP:0004817 | |
| MousePheno | increased variability of skeletal muscle fiber size | 1.25e-05 | 43 | 99 | 5 | MP:0009403 | |
| MousePheno | skeletal muscle fiber degeneration | 1.29e-05 | 21 | 99 | 4 | MP:0009412 | |
| MousePheno | decreased skeletal muscle size | 2.29e-05 | 81 | 99 | 6 | MP:0010240 | |
| MousePheno | muscle degeneration | 4.23e-05 | 55 | 99 | 5 | MP:0000749 | |
| MousePheno | abnormal skeletal muscle size | 5.02e-05 | 93 | 99 | 6 | MP:0009458 | |
| MousePheno | skeletal muscle degeneration | 5.63e-05 | 30 | 99 | 4 | MP:0009415 | |
| MousePheno | decreased muscle weight | 9.32e-05 | 34 | 99 | 4 | MP:0004232 | |
| MousePheno | increased skeletal muscle fiber size | 1.17e-04 | 36 | 99 | 4 | MP:0009399 | |
| MousePheno | abnormal muscle fiber morphology | MYH3 FLNC MYH4 MAGEL2 FKRP OBSCN LAMA2 RYR1 CHRNE ABCA5 ASAH1 | 1.38e-04 | 406 | 99 | 11 | MP:0004087 |
| MousePheno | abnormal skeletal muscle fiber type ratio | 1.78e-04 | 40 | 99 | 4 | MP:0009409 | |
| MousePheno | abnormal muscle morphology | MYH1 MYH3 FLNC MYH4 MAGEL2 FN1 ACACB FKRP OBSCN LAMA2 IDS ARAF RYR1 CHRNE ABCA5 ASAH1 B9D1 TRAPPC10 SMAD7 | 2.42e-04 | 1106 | 99 | 19 | MP:0002108 |
| MousePheno | abnormal skeletal muscle morphology | MYH1 MYH3 FLNC MYH4 MAGEL2 ACACB FKRP OBSCN LAMA2 RYR1 CHRNE ASAH1 | 2.43e-04 | 508 | 99 | 12 | MP:0000759 |
| MousePheno | abnormal muscle weight | 2.59e-04 | 44 | 99 | 4 | MP:0004233 | |
| MousePheno | impaired skeletal muscle contractility | 2.59e-04 | 44 | 99 | 4 | MP:0002841 | |
| Domain | Myosin_N | 3.27e-10 | 15 | 122 | 6 | PF02736 | |
| Domain | Myosin_N | 3.27e-10 | 15 | 122 | 6 | IPR004009 | |
| Domain | Myosin-like_IQ_dom | 1.74e-09 | 19 | 122 | 6 | IPR027401 | |
| Domain | - | 1.74e-09 | 19 | 122 | 6 | 4.10.270.10 | |
| Domain | Myosin_tail_1 | 8.77e-08 | 18 | 122 | 5 | PF01576 | |
| Domain | Myosin_tail | 8.77e-08 | 18 | 122 | 5 | IPR002928 | |
| Domain | Myosin_head_motor_dom | 1.60e-07 | 38 | 122 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.60e-07 | 38 | 122 | 6 | PS51456 | |
| Domain | Myosin_head | 1.60e-07 | 38 | 122 | 6 | PF00063 | |
| Domain | MYSc | 1.60e-07 | 38 | 122 | 6 | SM00242 | |
| Domain | IQ | 4.01e-07 | 71 | 122 | 7 | PF00612 | |
| Domain | IQ | 9.94e-07 | 81 | 122 | 7 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.04e-06 | 90 | 122 | 7 | IPR000048 | |
| Domain | IQ | 2.54e-06 | 93 | 122 | 7 | PS50096 | |
| Domain | Laminin_N | 1.43e-04 | 16 | 122 | 3 | IPR008211 | |
| Domain | LamNT | 1.43e-04 | 16 | 122 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 1.43e-04 | 16 | 122 | 3 | PS51117 | |
| Domain | Laminin_N | 1.43e-04 | 16 | 122 | 3 | PF00055 | |
| Domain | FN3 | 2.15e-04 | 185 | 122 | 7 | SM00060 | |
| Domain | Galactose-bd-like | 3.78e-04 | 94 | 122 | 5 | IPR008979 | |
| Domain | Laminin_domII | 4.18e-04 | 5 | 122 | 2 | IPR010307 | |
| Domain | Choline_transpo | 4.18e-04 | 5 | 122 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 4.18e-04 | 5 | 122 | 2 | IPR007603 | |
| Domain | Laminin_aI | 4.18e-04 | 5 | 122 | 2 | IPR009254 | |
| Domain | Laminin_I | 4.18e-04 | 5 | 122 | 2 | PF06008 | |
| Domain | Laminin_II | 4.18e-04 | 5 | 122 | 2 | PF06009 | |
| Domain | FN3_dom | 4.49e-04 | 209 | 122 | 7 | IPR003961 | |
| Domain | fn3 | 6.85e-04 | 162 | 122 | 6 | PF00041 | |
| Domain | EGF_LAM_2 | 9.71e-04 | 30 | 122 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 9.71e-04 | 30 | 122 | 3 | PS01248 | |
| Domain | LAMININ_IVA | 1.15e-03 | 8 | 122 | 2 | PS51115 | |
| Domain | Laminin_B | 1.15e-03 | 8 | 122 | 2 | PF00052 | |
| Domain | LamB | 1.15e-03 | 8 | 122 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.15e-03 | 8 | 122 | 2 | IPR000034 | |
| Domain | - | 1.33e-03 | 73 | 122 | 4 | 2.60.120.260 | |
| Domain | MAGE | 1.40e-03 | 34 | 122 | 3 | SM01373 | |
| Domain | EGF_Lam | 1.53e-03 | 35 | 122 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.53e-03 | 35 | 122 | 3 | PF00053 | |
| Domain | MAGE | 1.66e-03 | 36 | 122 | 3 | PS50838 | |
| Domain | MHD_dom | 1.66e-03 | 36 | 122 | 3 | IPR002190 | |
| Domain | MAGE | 1.66e-03 | 36 | 122 | 3 | PF01454 | |
| Domain | LAM_G_DOMAIN | 1.94e-03 | 38 | 122 | 3 | PS50025 | |
| Domain | Laminin_EGF | 1.94e-03 | 38 | 122 | 3 | IPR002049 | |
| Domain | FN3 | 1.97e-03 | 199 | 122 | 6 | PS50853 | |
| Domain | Laminin_G_2 | 2.25e-03 | 40 | 122 | 3 | PF02210 | |
| Domain | Ig-like_fold | FLNC FN1 HLA-DMA PILRB VSIG4 OBSCN MCAM NFASC PTPRZ1 CEACAM16 TNR USH2A | 2.26e-03 | 706 | 122 | 12 | IPR013783 |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.94e-07 | 70 | 97 | 7 | M12294 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 3.27e-05 | 27 | 97 | 4 | M39863 | |
| Pathway | WP_SPHINGOLIPID_PATHWAY | 5.03e-05 | 30 | 97 | 4 | M39501 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.75e-04 | 76 | 97 | 5 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 2.53e-04 | 45 | 97 | 4 | M27623 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 2.79e-04 | 84 | 97 | 5 | M7098 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 3.59e-12 | 6 | 127 | 5 | 10077619 | |
| Pubmed | 1.25e-11 | 7 | 127 | 5 | 35210422 | ||
| Pubmed | 1.70e-10 | 4 | 127 | 4 | 10388558 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 8.45e-10 | 5 | 127 | 4 | 3829126 | |
| Pubmed | 8.45e-10 | 5 | 127 | 4 | 6196357 | ||
| Pubmed | 2.53e-09 | 6 | 127 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 2.53e-09 | 6 | 127 | 4 | 10588881 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 5.88e-09 | 7 | 127 | 4 | 29758057 | |
| Pubmed | 5.88e-09 | 7 | 127 | 4 | 16819597 | ||
| Pubmed | 1.17e-08 | 8 | 127 | 4 | 26993635 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 4.76e-08 | 3 | 127 | 3 | 26059207 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 5.49e-08 | 11 | 127 | 4 | 16024798 | |
| Pubmed | 9.44e-08 | 31 | 127 | 5 | 21985497 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.18e-07 | 13 | 127 | 4 | 8404542 | |
| Pubmed | Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. | 1.18e-07 | 13 | 127 | 4 | 10694423 | |
| Pubmed | 1.65e-07 | 14 | 127 | 4 | 27184118 | ||
| Pubmed | 1.65e-07 | 14 | 127 | 4 | 33742095 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 20357587 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.90e-07 | 4 | 127 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.90e-07 | 4 | 127 | 3 | 18417546 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 11023856 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 2.24e-07 | 15 | 127 | 4 | 24852826 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | GLIPR1 LARGE2 FRAS1 MIA3 MAN2A2 GALNS FKRP GLRX3 MCAM LAMA5 GCNT1 LMBRD2 NRP2 SCAP RNFT1 UGT8 CERCAM SEC63 | 4.01e-07 | 1201 | 127 | 18 | 35696571 |
| Pubmed | 4.73e-07 | 5 | 127 | 3 | 6879174 | ||
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 4.73e-07 | 5 | 127 | 3 | 12919077 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 4.73e-07 | 5 | 127 | 3 | 30737693 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 MYH1 MYH3 MYH4 SRSF3 FN1 ADGRB1 OBSCN NFASC MAGEE2 RYR1 CCDC198 TNR RPL7 | 5.47e-07 | 736 | 127 | 14 | 29676528 |
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 20417199 | ||
| Pubmed | 9.43e-07 | 6 | 127 | 3 | 10444070 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 9.43e-07 | 6 | 127 | 3 | 17559643 | |
| Pubmed | Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. | 9.43e-07 | 6 | 127 | 3 | 19893454 | |
| Pubmed | 1.18e-06 | 22 | 127 | 4 | 24301466 | ||
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 2.02e-06 | 25 | 127 | 4 | 19373938 | |
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 33667029 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 19633172 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 2.63e-06 | 8 | 127 | 3 | 14667415 | |
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 3864153 | ||
| Pubmed | 2.63e-06 | 8 | 127 | 3 | 36200826 | ||
| Pubmed | 3.75e-06 | 29 | 127 | 4 | 22613833 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 31960486 | ||
| Pubmed | 3.93e-06 | 9 | 127 | 3 | 9882526 | ||
| Pubmed | 5.60e-06 | 10 | 127 | 3 | 19506036 | ||
| Pubmed | Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice. | 5.60e-06 | 10 | 127 | 3 | 8950513 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 6.39e-06 | 33 | 127 | 4 | 32094117 | |
| Pubmed | 7.68e-06 | 11 | 127 | 3 | 18310078 | ||
| Pubmed | 7.68e-06 | 11 | 127 | 3 | 8136524 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 7.68e-06 | 11 | 127 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 7.68e-06 | 11 | 127 | 3 | 29168801 | |
| Pubmed | 1.02e-05 | 12 | 127 | 3 | 14557543 | ||
| Pubmed | 1.26e-05 | 39 | 127 | 4 | 38690566 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 15013951 | ||
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.32e-05 | 2 | 127 | 2 | 9585413 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16226104 | ||
| Pubmed | Opposing effects of collagen I and vitronectin on fibronectin fibril structure and function. | 1.32e-05 | 2 | 127 | 2 | 24509439 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 16575183 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23811340 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 34605523 | ||
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.32e-05 | 2 | 127 | 2 | 9382868 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.32e-05 | 2 | 127 | 2 | 22337492 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 31115525 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 38216996 | ||
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 23652800 | ||
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.32e-05 | 2 | 127 | 2 | 11551968 | |
| Pubmed | Clinical significance of serum fibronectin and vitronectin levels in melanoma patients. | 1.32e-05 | 2 | 127 | 2 | 24999757 | |
| Pubmed | A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy. | 1.32e-05 | 2 | 127 | 2 | 29073160 | |
| Pubmed | The protein tyrosine phosphatase RPTPζ/phosphacan is critical for perineuronal net structure. | 1.32e-05 | 2 | 127 | 2 | 31822561 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 9722619 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 1.32e-05 | 2 | 127 | 2 | 7545970 | |
| Pubmed | Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. | 1.32e-05 | 2 | 127 | 2 | 15687502 | |
| Pubmed | 1.32e-05 | 2 | 127 | 2 | 21102503 | ||
| Pubmed | Vitronectin alters fibronectin organization at the cell-material interface. | 1.32e-05 | 2 | 127 | 2 | 23899674 | |
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.32e-05 | 2 | 127 | 2 | 11744674 | |
| Pubmed | Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. | 1.32e-05 | 13 | 127 | 3 | 7797078 | |
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 1.32e-05 | 13 | 127 | 3 | 21900571 | |
| Pubmed | 1.32e-05 | 13 | 127 | 3 | 8948582 | ||
| Pubmed | 1.68e-05 | 14 | 127 | 3 | 24938781 | ||
| Pubmed | 1.68e-05 | 14 | 127 | 3 | 38327785 | ||
| Pubmed | 1.68e-05 | 146 | 127 | 6 | 27068509 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 2.46e-05 | 46 | 127 | 4 | 28827394 | |
| Pubmed | 2.57e-05 | 16 | 127 | 3 | 16494860 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 2.57e-05 | 16 | 127 | 3 | 19922871 | |
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 3.11e-05 | 17 | 127 | 3 | 22351927 | |
| Pubmed | 3.11e-05 | 17 | 127 | 3 | 16124007 | ||
| Pubmed | 3.24e-05 | 164 | 127 | 6 | 32409323 | ||
| Pubmed | An overview of the MAGE gene family with the identification of all human members of the family. | 3.73e-05 | 18 | 127 | 3 | 11454705 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 3.73e-05 | 18 | 127 | 3 | 25753484 | |
| Pubmed | 3.73e-05 | 18 | 127 | 3 | 14730302 | ||
| Pubmed | 3.73e-05 | 18 | 127 | 3 | 11311202 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 36515178 | ||
| Pubmed | Evolution of testis-specific kinases TSSK1B and TSSK2 in primates. | 3.96e-05 | 3 | 127 | 2 | 23258646 | |
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 7781606 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 30396333 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 25567808 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 23339872 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 3904738 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 12091360 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 33105833 | ||
| Pubmed | 3.96e-05 | 3 | 127 | 2 | 10364433 | ||
| Interaction | CEACAM8 interactions | 4.48e-08 | 119 | 122 | 9 | int:CEACAM8 | |
| Interaction | SCGB2A2 interactions | LARGE2 MAN2A2 GALNS FN1 GLB1L LAMA5 GCNT1 NRP2 UGT8 CERCAM GASK1A | 1.14e-07 | 223 | 122 | 11 | int:SCGB2A2 |
| Interaction | GPIHBP1 interactions | 1.49e-06 | 133 | 122 | 8 | int:GPIHBP1 | |
| Interaction | ASAH2 interactions | 4.27e-06 | 6 | 122 | 3 | int:ASAH2 | |
| Interaction | LYZL1 interactions | 7.58e-06 | 118 | 122 | 7 | int:LYZL1 | |
| Interaction | IFNE interactions | 2.01e-05 | 27 | 122 | 4 | int:IFNE | |
| Interaction | TEDDM1 interactions | 3.63e-05 | 2 | 122 | 2 | int:TEDDM1 | |
| Interaction | RSPH6A interactions | 5.15e-05 | 34 | 122 | 4 | int:RSPH6A | |
| Interaction | PRKAG2 interactions | 5.75e-05 | 68 | 122 | 5 | int:PRKAG2 | |
| Interaction | TMEM260 interactions | 5.92e-05 | 13 | 122 | 3 | int:TMEM260 | |
| Interaction | CNTN1 interactions | 6.17e-05 | 69 | 122 | 5 | int:CNTN1 | |
| Interaction | DEFB109B interactions | 8.05e-05 | 38 | 122 | 4 | int:DEFB109B | |
| Interaction | FAM229B interactions | 1.09e-04 | 3 | 122 | 2 | int:FAM229B | |
| Interaction | SLC22A25 interactions | 1.09e-04 | 3 | 122 | 2 | int:SLC22A25 | |
| Interaction | CFC1 interactions | 1.19e-04 | 126 | 122 | 6 | int:CFC1 | |
| Interaction | PDGFRA interactions | PDXDC1 LARGE2 MAN2A2 GALNS GLB1L LAMA5 GCNT1 B3GNT3 UGT8 CERCAM | 1.19e-04 | 385 | 122 | 10 | int:PDGFRA |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 5.74e-07 | 346 | 127 | 9 | chr17p13 | |
| Cytoband | 19p13.1 | 3.26e-04 | 48 | 127 | 3 | 19p13.1 | |
| Cytoband | 17p13.1 | 3.36e-04 | 118 | 127 | 4 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 5.25e-04 | 503 | 127 | 7 | chr6p21 | |
| Cytoband | 4q21.21 | 7.79e-04 | 15 | 127 | 2 | 4q21.21 | |
| Cytoband | 17q23.1 | 8.88e-04 | 16 | 127 | 2 | 17q23.1 | |
| Cytoband | 8q21.11 | 2.74e-03 | 28 | 127 | 2 | 8q21.11 | |
| GeneFamily | Myosin heavy chains | 5.56e-09 | 15 | 84 | 5 | 1098 | |
| GeneFamily | Fibronectin type III domain containing | 1.01e-04 | 160 | 84 | 6 | 555 | |
| GeneFamily | MAGE family | 8.44e-04 | 40 | 84 | 3 | 1136 | |
| GeneFamily | Laminin subunits | 1.37e-03 | 12 | 84 | 2 | 626 | |
| GeneFamily | ATP binding cassette subfamily A | 1.87e-03 | 14 | 84 | 2 | 805 | |
| GeneFamily | Sulfatases | 3.11e-03 | 18 | 84 | 2 | 410 | |
| GeneFamily | Proteases, serine | 3.14e-03 | 63 | 84 | 3 | 738 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.71e-08 | 186 | 125 | 8 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.85e-07 | 155 | 125 | 7 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-07 | 162 | 125 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-07 | 178 | 125 | 7 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | PCW_10-12-Hematologic_Myeloid|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 195 | 125 | 7 | 6352cd749091cfdbf5cce3c354fa57883cc513e8 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.38e-06 | 196 | 125 | 7 | 3fd5567ea14193181929134c377e8a38fb4f47fd | |
| ToppCell | 15-Distal-Immune-Hematopoietic,_Macrophage|Distal / Age, Tissue, Lineage and Cell class | 1.48e-06 | 198 | 125 | 7 | 0e4aa6c7d74c5b1bb26996df1be3d58f998d18ac | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 144 | 125 | 6 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.77e-06 | 163 | 125 | 6 | f558ad9569e5137e62a601ba4f073e69ed8f8650 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-06 | 166 | 125 | 6 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-06 | 168 | 125 | 6 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-06 | 170 | 125 | 6 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-06 | 170 | 125 | 6 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 173 | 125 | 6 | 9019049b1e2a24cb0bbbc620d64ef29dd18cc4c6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-06 | 173 | 125 | 6 | 077029eecfe636a5baf5f70464e1713b3f6b4274 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 125 | 6 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 175 | 125 | 6 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-05 | 178 | 125 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 180 | 125 | 6 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.23e-05 | 181 | 125 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.27e-05 | 182 | 125 | 6 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 182 | 125 | 6 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 182 | 125 | 6 | 84f4322ec3d12cb217009f9215af01ebfabc82b4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 182 | 125 | 6 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-05 | 182 | 125 | 6 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-05 | 182 | 125 | 6 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 183 | 125 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 184 | 125 | 6 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 185 | 125 | 6 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 185 | 125 | 6 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 185 | 125 | 6 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-05 | 185 | 125 | 6 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.48e-05 | 110 | 125 | 5 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.48e-05 | 187 | 125 | 6 | b5cb8760fa667c237902d50a78dea4cb1babd607 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 187 | 125 | 6 | daff7ccd3f1924cf2b34d3aca3eccde245aaf371 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 187 | 125 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 187 | 125 | 6 | 5b7a1edee602e55d3400dc17dbb6b8aaa26defc0 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 54 | 125 | 4 | 13431c23a110070a11de41773233a8d6583d902c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Efna5_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 54 | 125 | 4 | cd64ee5c47df5dba0cea954cb115a8de0efb55d1 | |
| ToppCell | COVID-19-Heart-Fib_+_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 112 | 125 | 5 | d00ee6b19e41a35450681fe676885983536d6292 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.67e-05 | 191 | 125 | 6 | c383ae386bc53e73a683a9543c7dfed2a65257c5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 191 | 125 | 6 | 51f5af610983aa73b9f4ece6f27d281ebff89a04 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 191 | 125 | 6 | 8fd6bdc9d2b1c8d364221d7bc68d03921b668ab5 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-05 | 191 | 125 | 6 | 5c0c44612b4cdbf89c0f1f219416374a7541f610 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 55 | 125 | 4 | b0d37faccc8d04433ee0e76cbce2410530c4c8a1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nefm_(Layer_6a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.74e-05 | 55 | 125 | 4 | c3ebea1420b68638ed465a8cd8efba860650b795 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 194 | 125 | 6 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-05 | 194 | 125 | 6 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 194 | 125 | 6 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-05 | 194 | 125 | 6 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 194 | 125 | 6 | 6810586080cc893e3270b9c8bee2d95ed78e2893 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 195 | 125 | 6 | c707885d092aedbbe14f51f7de4a5911c9214289 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 195 | 125 | 6 | 799992721369357484300fe218aff075154c3148 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 195 | 125 | 6 | 630bfe5b192d247bab7cf8bc5a0780c7f8d67501 | |
| ToppCell | distal-1-Hematologic-Interstitial_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.99e-05 | 197 | 125 | 6 | 9e5df74aeeefa4d928ec07c036aacb549c797f30 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 197 | 125 | 6 | d0c6b2d22470ff1134b676ed9296fa7a55d915e7 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-05 | 198 | 125 | 6 | a41d0a6e5f9f30a48bb7fed431a3e8257f62f955 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.04e-05 | 198 | 125 | 6 | d42fce8e547dc97f3cf144ab65483a1b11ace267 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | 3981873eceb69412ec02a35a734965472853c3fc | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-05 | 200 | 125 | 6 | c439d4c62732ad660a60bc6577a4a6ca0f32a5b7 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 200 | 125 | 6 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.16e-05 | 200 | 125 | 6 | f5f24273bee3259a4a3be99ba53b88defa1286c0 | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.16e-05 | 200 | 125 | 6 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-05 | 200 | 125 | 6 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.72e-05 | 140 | 125 | 5 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 145 | 125 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.57e-05 | 77 | 125 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.97e-05 | 152 | 125 | 5 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.97e-05 | 152 | 125 | 5 | fc9472bc19f997103da535b035105f01429cb08e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-05 | 160 | 125 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 161 | 125 | 5 | ed93cb6c133855a5c244821e1a260aae8ab4df9a | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.15e-05 | 161 | 125 | 5 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-05 | 161 | 125 | 5 | 0089d7bb305c592392791862a3341fc92af8f3e2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.15e-05 | 161 | 125 | 5 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.42e-05 | 162 | 125 | 5 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 162 | 125 | 5 | 2787be283b7a705647058aeb9bc54006ce5ffe95 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.42e-05 | 162 | 125 | 5 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-05 | 164 | 125 | 5 | 90afae3cca108ebfb44ff2ec4adcbb8c68a0bdf2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.98e-05 | 164 | 125 | 5 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 168 | 125 | 5 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 169 | 125 | 5 | 922086f218135b734b7d370b871923e50141edce | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.15e-04 | 169 | 125 | 5 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-04 | 169 | 125 | 5 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.18e-04 | 170 | 125 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 1.18e-04 | 170 | 125 | 5 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.21e-04 | 171 | 125 | 5 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 125 | 5 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 172 | 125 | 5 | a5344760b10ecdc0101f78b93b8fc0f8107068c5 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 173 | 125 | 5 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 173 | 125 | 5 | 6d2ceba4f89a228600e2b40aba81bb0eb81578c0 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 173 | 125 | 5 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-04 | 173 | 125 | 5 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| Drug | formycin triphosphate | 3.09e-07 | 51 | 122 | 6 | CID000122274 | |
| Drug | purealin | 6.74e-07 | 58 | 122 | 6 | CID006419303 | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 1.05e-06 | 194 | 122 | 9 | 7534_DN | |
| Drug | fast white | 2.95e-06 | 42 | 122 | 5 | CID000024008 | |
| Drug | blebbistatin | 3.07e-06 | 116 | 122 | 7 | CID003476986 | |
| Drug | AC1L1IZ2 | 5.73e-06 | 304 | 122 | 10 | CID000004795 | |
| Drug | SM-2 | 7.41e-06 | 87 | 122 | 6 | CID000486033 | |
| Drug | AC1MNW2Q | 9.50e-06 | 53 | 122 | 5 | CID003359491 | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 3204_UP | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 6673_DN | |
| Drug | 4-chloroaniline | 1.36e-05 | 202 | 122 | 8 | CID000007812 | |
| Drug | AC1N9ZZC | 1.59e-05 | 149 | 122 | 7 | CID004369374 | |
| Drug | S-(-)-Etomoxir | 1.65e-05 | 100 | 122 | 6 | CID000060765 | |
| Drug | carvedilol | 2.63e-05 | 161 | 122 | 7 | CID000002585 | |
| Drug | DB04780 | 3.73e-05 | 170 | 122 | 7 | CID005459389 | |
| Drug | B0683 | 4.03e-05 | 117 | 122 | 6 | CID006398969 | |
| Drug | oxovanadium | 4.64e-05 | 120 | 122 | 6 | CID000024411 | |
| Drug | cerbroside | 5.91e-05 | 77 | 122 | 5 | CID000025437 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.54e-10 | 10 | 120 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 7.92e-10 | 12 | 120 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 7.92e-10 | 12 | 120 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.28e-09 | 13 | 120 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.97e-09 | 15 | 120 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.26e-08 | 48 | 120 | 6 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.60e-07 | 71 | 120 | 6 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 9.38e-07 | 80 | 120 | 6 | DOID:12930 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 1.40e-05 | 12 | 120 | 3 | cv:C0699743 | |
| Disease | Multiple pterygium syndrome | 9.79e-05 | 4 | 120 | 2 | C0265261 | |
| Disease | tenascin-R measurement | 2.43e-04 | 6 | 120 | 2 | EFO_0803139 | |
| Disease | Glioblastoma | 3.09e-04 | 79 | 120 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 3.91e-04 | 84 | 120 | 4 | C0334588 | |
| Disease | cathepsin S measurement | 4.52e-04 | 8 | 120 | 2 | EFO_0008073 | |
| Disease | interleukin-36 alpha measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0021851 | |
| Disease | tryptase beta-2 measurement | 5.80e-04 | 9 | 120 | 2 | EFO_0008306 | |
| Disease | Crohn's disease of large bowel | 7.69e-04 | 44 | 120 | 3 | C0156147 | |
| Disease | IIeocolitis | 7.69e-04 | 44 | 120 | 3 | C0949272 | |
| Disease | Crohn's disease of the ileum | 7.69e-04 | 44 | 120 | 3 | C0267380 | |
| Disease | Regional enteritis | 7.69e-04 | 44 | 120 | 3 | C0678202 | |
| Disease | Glioblastoma Multiforme | 1.11e-03 | 111 | 120 | 4 | C1621958 | |
| Disease | Crohn Disease | 1.12e-03 | 50 | 120 | 3 | C0010346 | |
| Disease | hypertension | 1.64e-03 | 307 | 120 | 6 | EFO_0000537 | |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 1.66e-03 | 15 | 120 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | neutrophil collagenase measurement | 1.90e-03 | 16 | 120 | 2 | EFO_0008248 | |
| Disease | muscular dystrophy (is_implicated_in) | 2.14e-03 | 17 | 120 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | macrophage inflammatory protein 1b measurement | 2.35e-03 | 136 | 120 | 4 | EFO_0008219 | |
| Disease | inferior parietal cortex volume measurement | 2.68e-03 | 19 | 120 | 2 | EFO_0010307 | |
| Disease | serum albumin measurement | 2.95e-03 | 592 | 120 | 8 | EFO_0004535 | |
| Disease | myocardial infarction | 3.14e-03 | 350 | 120 | 6 | EFO_0000612 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 3.27e-03 | 21 | 120 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Arthrogryposis | 3.27e-03 | 21 | 120 | 2 | C0003886 | |
| Disease | platelet component distribution width | 3.77e-03 | 755 | 120 | 9 | EFO_0007984 | |
| Disease | malignant astrocytoma (is_marker_for) | 3.92e-03 | 23 | 120 | 2 | DOID:3069 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YNPWDRLSVAVISPY | 1201 | Q8WWZ7 | |
| GYDWVGIPLVYTQVV | 226 | Q8N1M1 | |
| YWENLRIASGRPYNP | 351 | Q93088 | |
| NEWPPERIIQYYGPA | 481 | Q14264 | |
| YTNWAYVPFPPLIRA | 101 | Q902F8 | |
| YTNWAYVPFPPLIRA | 101 | Q9UKH3 | |
| EGIAYWEPPTYIRCV | 621 | O14514 | |
| LVYAWYRGPASEPNR | 346 | Q2WEN9 | |
| QLYQHVPETRWPIVY | 6 | Q96DB2 | |
| VPETRWPIVYSPRYN | 11 | Q96DB2 | |
| WPIVYSPRYNITFMG | 16 | Q96DB2 | |
| TYQQPRLTAWYGELP | 126 | Q96Q83 | |
| LPPTVDWRQYGITLY | 4421 | Q86UQ4 | |
| LWEIYSFGRVPYPRI | 376 | P41240 | |
| PTYRGAVPWYTINLD | 41 | Q13510 | |
| INGASYLRLPWVNPY | 181 | Q6W2J9 | |
| YLRLPWVNPYMEGAT | 186 | Q6W2J9 | |
| VWEGYPIQSTIPSQY | 166 | Q96G23 | |
| YEGGSVTWLPPAIYR | 131 | Q04844 | |
| SIYGRSPEEWPNLAY | 441 | Q01432 | |
| GDYWRLLNPGEYVVT | 676 | Q8N436 | |
| YVVREPGQSPIFWYA | 981 | P52333 | |
| QWAANYEPYVVVPRD | 611 | Q8N3Y3 | |
| QPEEWYSPGIYELRR | 86 | Q96RI1 | |
| SYQYWPVLVPRGIRL | 16 | Q6TCH7 | |
| IYIPPYAELRGGSWV | 2191 | O00763 | |
| IEYGPAQLYWEPAEV | 576 | Q9Y4B6 | |
| EPGTQLYDWPYRFLR | 186 | O60496 | |
| PEIWIQLNYLPSYGT | 1746 | Q86XX4 | |
| VYPGWPIYPRNRYTS | 221 | P48060 | |
| PRYQFLWGPRAYAET | 266 | P43366 | |
| SYSNPVEYELLWGPR | 456 | Q8TD90 | |
| RIPYTEPAEYEFLWG | 1171 | Q9UJ55 | |
| GLYAPYWEPSARGII | 366 | Q14409 | |
| TEQSLYYRQWTVPRP | 1306 | Q4ZG55 | |
| PVYPDLAEVVGYQWS | 226 | A8MXV4 | |
| SWPTYPQLYVSGELI | 196 | O76003 | |
| DYVIGMNPSQRYPLW | 226 | Q96T54 | |
| WLPVYKPEVVTAYRG | 131 | Q9UKX2 | |
| YVDDPNWSGIGVVRY | 511 | Q6P996 | |
| CDVRYWPTEPGEYAV | 626 | Q14315 | |
| IPAQYVRVYPERWSP | 566 | O60462 | |
| EGYALVSRPIRWYPN | 2346 | P24043 | |
| VNPYKWLPVYNAEVV | 126 | P12882 | |
| WLPVYNAEVVTAYRG | 131 | P12882 | |
| ELYWQAPPSYLGDRV | 1691 | O15230 | |
| PSGRVVTQYHYTQWP | 1886 | P23471 | |
| NMLRIVEPYIAWGYP | 131 | P18124 | |
| VWKPVESYGPVTYIV | 7576 | Q5VST9 | |
| WYQQTPGQAPRTLIY | 61 | A0A075B6I0 | |
| VWGSRYVVGQTPVYV | 781 | O94856 | |
| YTQTPWRRIPGGYSA | 766 | Q9H7U1 | |
| PNIPVYRDWEMVGRY | 176 | P34059 | |
| LPYRYTDGGARPVIW | 356 | Q9UFP1 | |
| YYWEVPPSEVQLLKR | 301 | P10398 | |
| LYPRAWTVYQLPGQN | 231 | Q9HCG7 | |
| WSRPQAPITGYRIVY | 831 | P02751 | |
| YGVEPLWRASDYVPS | 156 | A6NCJ1 | |
| VQQYVPEEWAEYPRP | 56 | O60883 | |
| QPGHPVNRTIYWIDY | 436 | Q16880 | |
| YWTKQGPQQTLYVPR | 576 | Q6UWU2 | |
| YTAIAYWVPRNALPS | 211 | P28067 | |
| AYTPVVVTQWYRAPE | 581 | Q9UQ88 | |
| NVGPIRAFWSKYYVP | 241 | Q9Y2A9 | |
| VPPGKNYTYVWPVRE | 156 | Q6MZM0 | |
| YYTVNGSWVVPPEPR | 91 | P49641 | |
| WCVIPRDDPLVLYVY | 566 | Q7Z6J4 | |
| WENLVYILRPPVEAY | 166 | Q8NEG0 | |
| RIVQDTAPPLNYYWV | 626 | Q8IWA5 | |
| WLYGDPRQVLYPRNS | 56 | Q53GD3 | |
| IAYSQYPRPSDIPQW | 461 | P22304 | |
| VGDTPAYLYEERWTP | 301 | Q9H9S5 | |
| YSPDEYLWATIQRIP | 316 | Q02742 | |
| YAAVVWRPEGEPRFY | 91 | Q5T4B2 | |
| STNPYGWPQIVLSVY | 76 | Q9UPM9 | |
| LPPLQENWYGRYSTA | 61 | Q9NVL8 | |
| IYSRPLPWIIYGVFA | 491 | Q6T423 | |
| QPEWYVGAPVAYVQQ | 81 | Q12770 | |
| PVFWSQVGYRYNPRP | 331 | Q9Y2H2 | |
| LRVGWALTEGYTPYP | 681 | P21817 | |
| IVWGNPQITVYPYKE | 2451 | Q6ZTR5 | |
| LYIGWAPARYVVAVG | 326 | Q8WY07 | |
| AWNVPPGVYAVVDLY | 661 | Q96JN8 | |
| VPWERAISPNKVPYY | 356 | Q13474 | |
| IAWYEDRQVPGGYTV | 231 | Q93099 | |
| LQVEPYYPRSLQDWG | 446 | Q9H239 | |
| YYPRSLQDWGGIPEE | 451 | Q9H239 | |
| CVGRNGYPIPQVIWY | 161 | P43121 | |
| FLTVYEWRSPYGLTP | 591 | O60391 | |
| CHIYYNWPGVIRVPA | 816 | Q96J94 | |
| FDGTRVYSPPEWIRY | 201 | P11309 | |
| PDYWYPQDLQARARV | 81 | P30711 | |
| WRKPIQSNGPIIYYI | 3521 | O75445 | |
| LGGRLVYWLPVYTPE | 366 | Q7Z4G4 | |
| RPGVYTRVPAYVNWI | 251 | Q9NRR2 | |
| FPGVYTHVQIYVPWI | 291 | A6NIE9 | |
| FITPPYVYEILVWCV | 286 | Q96RI9 | |
| PVYVYYKLARGWPEV | 71 | Q5JRA6 | |
| FILYRPVSGYPWQDD | 176 | Q5T9Z0 | |
| YIPDGIMPIFWRVVY | 101 | Q68DH5 | |
| PARVQGYPWRLAYST | 796 | Q8NI08 | |
| WETVPNYLPPDTRVY | 271 | Q9HC36 | |
| RPPSQWTMEGYLYVQ | 261 | A6NI28 | |
| GWYPGLEQRYRQAIP | 236 | Q2M3M2 | |
| WLPVYNPEVVTAYRG | 131 | Q9Y623 | |
| WLPVYNPEVVEGYRG | 131 | P11055 | |
| HSPRIVLPVWLNYYG | 61 | Q6RSH7 | |
| VILYILLVGYPPFWD | 201 | Q9UQM7 | |
| LTGWGYRVIALQYPV | 66 | Q9NZD8 | |
| IIWPYGTGEVIVQNY | 171 | Q9UJT1 | |
| ELCQYYRTFVPIPVW | 291 | Q5M7Z0 | |
| EVDGVWVYNRSSYPI | 326 | O15105 | |
| GYYGPLRSVWVARNP | 31 | P84103 | |
| FPGVYTRVSNFVPWI | 821 | Q7RTY8 | |
| WQPPRAEIENYVLTY | 1061 | Q92752 | |
| PLRRGYVRVQWYPEG | 116 | Q9C0C9 | |
| WLPVYKPEVVAAYRG | 131 | Q9UKX3 | |
| IVIPATYYLWPRDQN | 26 | Q9UGP8 | |
| QARGSPPISYIWYKQ | 166 | Q9Y279 | |
| HWYRQLPSQGPEYVI | 51 | A0A0B4J265 | |
| YYPWELAIVPNVRIS | 56 | Q9UKJ0 | |
| WTVVRTYAPYVTFPV | 6 | Q96EX1 | |
| VGIIYNPVEYAWEPH | 51 | Q53HV7 | |
| VLQGIPYQPKVYDIW | 186 | Q9BXA7 | |
| PYQPKVYDIWSLGVI | 191 | Q9BXA7 | |
| KRTIYTAGRPPWYNE | 76 | Q9NWZ5 | |
| WFVLPHIYPIVQYDV | 766 | P48553 | |
| PGRAQIPVYWEGYVR | 66 | Q9BUB7 | |
| IPVYWEGYVRFLNTP | 71 | Q9BUB7 | |
| YRWEVLIIGPPDTLY | 36 | P62253 | |
| QGRLSWPVLFLYPEY | 271 | O95801 | |
| PYQPKVYDIWSLGVI | 191 | Q96PF2 | |
| TVDPPYPRSIAQYWL | 456 | P04004 | |
| EYYNNNRTTPVWPIP | 206 | Q9P2T0 | |
| PARRQGYGPLWYTSV | 191 | Q06643 | |
| YYNRALSGWEPFIEP | 2756 | Q5THJ4 | |
| LYTQYNRVWIPDPEE | 6 | Q9NQX4 |